Company / PP&E per Share
Trevi Therapeutics, Inc. PP&E per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2024
5-year range
$0.00 / $0.01
FY2020-FY2024
Trend
-29.4%
vs FY2023
Sector context
#183 of 191
Health Care
What the data says
Among 191 Health Care companies, Trevi Therapeutics, Inc. is in the bottom 4% for pp&e per share. Declined from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of -31.3%.
Declined from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -12.8%
- 5-Year CAGR
- -31.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 191This company $0.00 Sector average $22.34
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share decreased 29.4% year-over-year.
- Ranks #183 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -29.4% |
| FY2023 | $0.00 | -17.2% |
| FY2022 | $0.00 | +13.5% |
| FY2021 | $0.00 | -59.3% |
| FY2020 | $0.01 | -43.3% |
| FY2019 | $0.01 | -97.0% |
| FY2018 | $0.34 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026